| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinol-Binding Proteins, Plasma | 23 | 2020 | 94 | 5.460 |
Why?
|
| Insulin Resistance | 87 | 2024 | 3959 | 5.440 |
Why?
|
| Monosaccharide Transport Proteins | 66 | 2005 | 440 | 5.150 |
Why?
|
| Adipocytes | 44 | 2024 | 1179 | 4.210 |
Why?
|
| Glucose Transporter Type 4 | 59 | 2021 | 240 | 3.530 |
Why?
|
| Glucose | 83 | 2024 | 4351 | 3.510 |
Why?
|
| Adipose Tissue | 73 | 2022 | 3301 | 3.410 |
Why?
|
| Insulin | 107 | 2023 | 6597 | 3.290 |
Why?
|
| Fatty Acids | 23 | 2024 | 1804 | 3.140 |
Why?
|
| Muscle Proteins | 41 | 2005 | 1152 | 3.110 |
Why?
|
| Esters | 10 | 2022 | 211 | 2.690 |
Why?
|
| Leptin | 27 | 2024 | 1591 | 2.370 |
Why?
|
| AMP-Activated Protein Kinases | 16 | 2024 | 600 | 2.310 |
Why?
|
| Stearic Acids | 7 | 2024 | 56 | 2.160 |
Why?
|
| Hypothalamus | 15 | 2016 | 998 | 2.140 |
Why?
|
| Obesity | 59 | 2024 | 12922 | 2.010 |
Why?
|
| Palmitic Acid | 6 | 2024 | 149 | 1.920 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 18 | 2015 | 95 | 1.910 |
Why?
|
| Muscle, Skeletal | 46 | 2021 | 4925 | 1.570 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2023 | 12293 | 1.420 |
Why?
|
| Muscles | 31 | 2007 | 1581 | 1.410 |
Why?
|
| Lipogenesis | 6 | 2017 | 210 | 1.270 |
Why?
|
| Retinol-Binding Proteins | 6 | 2009 | 67 | 1.250 |
Why?
|
| Protein Tyrosine Phosphatases | 11 | 2007 | 459 | 1.250 |
Why?
|
| Multienzyme Complexes | 8 | 2006 | 666 | 1.200 |
Why?
|
| Liver | 35 | 2021 | 7509 | 1.180 |
Why?
|
| Blood Glucose | 39 | 2021 | 6381 | 1.100 |
Why?
|
| Mice | 134 | 2024 | 81208 | 1.090 |
Why?
|
| Homeostasis | 25 | 2022 | 3306 | 1.060 |
Why?
|
| Animals | 193 | 2024 | 167963 | 1.030 |
Why?
|
| Energy Metabolism | 22 | 2021 | 2869 | 1.000 |
Why?
|
| Glucose Intolerance | 12 | 2021 | 580 | 1.000 |
Why?
|
| Hydroxy Acids | 2 | 2022 | 19 | 0.970 |
Why?
|
| Eating | 13 | 2018 | 1539 | 0.940 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 264 | 0.920 |
Why?
|
| Phosphatidylinositol 3-Kinases | 24 | 2012 | 2864 | 0.900 |
Why?
|
| Enzyme Activation | 14 | 2024 | 3602 | 0.890 |
Why?
|
| Insulin-Secreting Cells | 2 | 2022 | 907 | 0.890 |
Why?
|
| Isoenzymes | 9 | 2009 | 1690 | 0.870 |
Why?
|
| Adipose Tissue, White | 6 | 2020 | 365 | 0.870 |
Why?
|
| Signal Transduction | 56 | 2021 | 23376 | 0.860 |
Why?
|
| Mice, Knockout | 46 | 2024 | 14372 | 0.830 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2022 | 3455 | 0.820 |
Why?
|
| Receptor, Insulin | 20 | 2018 | 836 | 0.810 |
Why?
|
| Diabetes Mellitus, Experimental | 15 | 2019 | 1112 | 0.800 |
Why?
|
| Adenylate Kinase | 5 | 2013 | 102 | 0.790 |
Why?
|
| Subcutaneous Fat | 3 | 2018 | 393 | 0.780 |
Why?
|
| Prealbumin | 4 | 2014 | 222 | 0.780 |
Why?
|
| Oxidation-Reduction | 5 | 2024 | 2222 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 38 | 2024 | 22023 | 0.770 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 726 | 0.750 |
Why?
|
| Thiazolidinediones | 6 | 2020 | 465 | 0.720 |
Why?
|
| Acyltransferases | 1 | 2022 | 305 | 0.710 |
Why?
|
| Stearates | 1 | 2019 | 6 | 0.700 |
Why?
|
| Body Weight | 25 | 2017 | 4611 | 0.690 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 580 | 0.640 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2021 | 317 | 0.640 |
Why?
|
| Glucose Tolerance Test | 18 | 2019 | 1175 | 0.630 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 348 | 0.630 |
Why?
|
| Biological Transport | 25 | 2007 | 2086 | 0.620 |
Why?
|
| Dietary Fats | 12 | 2022 | 1992 | 0.620 |
Why?
|
| Adipose Tissue, Brown | 8 | 2018 | 755 | 0.610 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2019 | 1245 | 0.600 |
Why?
|
| 3T3 Cells | 13 | 2017 | 1085 | 0.590 |
Why?
|
| Protein Kinase C | 7 | 2016 | 1199 | 0.570 |
Why?
|
| Lipid Metabolism | 11 | 2022 | 1902 | 0.560 |
Why?
|
| Adipogenesis | 3 | 2018 | 358 | 0.540 |
Why?
|
| PPAR gamma | 5 | 2020 | 484 | 0.540 |
Why?
|
| Paneth Cells | 1 | 2016 | 98 | 0.530 |
Why?
|
| Phosphorylation | 27 | 2020 | 8313 | 0.520 |
Why?
|
| Immunoassay | 2 | 2012 | 746 | 0.520 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 1173 | 0.520 |
Why?
|
| Inflammasomes | 1 | 2020 | 530 | 0.510 |
Why?
|
| Mice, Obese | 8 | 2024 | 420 | 0.500 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 2014 | 46 | 0.490 |
Why?
|
| Metabolomics | 2 | 2021 | 1628 | 0.480 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2014 | 10 | 0.470 |
Why?
|
| Neurons | 13 | 2018 | 9426 | 0.470 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 101 | 0.460 |
Why?
|
| Deoxyglucose | 8 | 2017 | 333 | 0.460 |
Why?
|
| Th1 Cells | 2 | 2016 | 1032 | 0.460 |
Why?
|
| Gene Expression Regulation | 22 | 2021 | 11903 | 0.460 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 967 | 0.450 |
Why?
|
| Glycogen | 11 | 2007 | 251 | 0.440 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 482 | 0.430 |
Why?
|
| Diet | 7 | 2021 | 8010 | 0.420 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 30 | 0.410 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 459 | 0.400 |
Why?
|
| Rats | 43 | 2021 | 23711 | 0.400 |
Why?
|
| Glucose Transporter Type 1 | 10 | 2017 | 186 | 0.400 |
Why?
|
| Thinness | 4 | 2014 | 491 | 0.390 |
Why?
|
| Male | 121 | 2024 | 359744 | 0.390 |
Why?
|
| Hormones | 3 | 2007 | 867 | 0.390 |
Why?
|
| Lipids | 6 | 2022 | 3336 | 0.390 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5791 | 0.390 |
Why?
|
| Fatty Liver | 3 | 2016 | 778 | 0.380 |
Why?
|
| Mice, Transgenic | 27 | 2017 | 9530 | 0.370 |
Why?
|
| Glycolysis | 6 | 2021 | 828 | 0.370 |
Why?
|
| Gene Expression | 16 | 2017 | 7588 | 0.370 |
Why?
|
| Receptors, Adrenergic | 1 | 2011 | 155 | 0.360 |
Why?
|
| Hypoglycemia | 3 | 2016 | 888 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2005 | 4490 | 0.360 |
Why?
|
| Animal Feed | 3 | 2008 | 112 | 0.360 |
Why?
|
| Diabetes Mellitus | 14 | 2012 | 5889 | 0.360 |
Why?
|
| Lipolysis | 4 | 2020 | 211 | 0.350 |
Why?
|
| Antigen Presentation | 1 | 2016 | 1254 | 0.350 |
Why?
|
| Cell Survival | 2 | 2019 | 5797 | 0.350 |
Why?
|
| Fasting | 12 | 2021 | 1603 | 0.350 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2010 | 112 | 0.350 |
Why?
|
| Fenretinide | 1 | 2009 | 9 | 0.350 |
Why?
|
| Glucose Clamp Technique | 10 | 2016 | 263 | 0.350 |
Why?
|
| Membrane Transport Proteins | 2 | 2010 | 1035 | 0.350 |
Why?
|
| Serine | 3 | 2016 | 830 | 0.340 |
Why?
|
| Retinoids | 1 | 2009 | 98 | 0.330 |
Why?
|
| Transcription Factors | 7 | 2017 | 12103 | 0.330 |
Why?
|
| Macrophages | 7 | 2020 | 5745 | 0.330 |
Why?
|
| Models, Biological | 16 | 2020 | 9467 | 0.320 |
Why?
|
| Down-Regulation | 3 | 2014 | 2913 | 0.320 |
Why?
|
| Insulin Receptor Substrate Proteins | 10 | 2010 | 557 | 0.310 |
Why?
|
| Glycogen Synthase | 5 | 2005 | 62 | 0.310 |
Why?
|
| RNA, Messenger | 30 | 2018 | 12766 | 0.310 |
Why?
|
| 3T3-L1 Cells | 4 | 2024 | 209 | 0.300 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2015 | 140 | 0.300 |
Why?
|
| Hypoglycemic Agents | 5 | 2010 | 3150 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2012 | 2448 | 0.300 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 1077 | 0.300 |
Why?
|
| Colitis | 1 | 2016 | 1229 | 0.300 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 4 | 1997 | 436 | 0.290 |
Why?
|
| Transgenes | 3 | 2013 | 1006 | 0.280 |
Why?
|
| Mice, Inbred NOD | 2 | 2022 | 1837 | 0.270 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2002 | 489 | 0.270 |
Why?
|
| Triglycerides | 6 | 2022 | 2476 | 0.270 |
Why?
|
| Sirtuin 1 | 3 | 2014 | 247 | 0.270 |
Why?
|
| Humans | 114 | 2024 | 760621 | 0.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 4353 | 0.260 |
Why?
|
| Mitochondrial Proteins | 4 | 2011 | 979 | 0.260 |
Why?
|
| Genes, ras | 3 | 1998 | 655 | 0.260 |
Why?
|
| Mass Spectrometry | 5 | 2018 | 2192 | 0.250 |
Why?
|
| Blotting, Western | 13 | 2016 | 5039 | 0.250 |
Why?
|
| Vitamin A | 5 | 2014 | 613 | 0.250 |
Why?
|
| Cells, Cultured | 18 | 2020 | 18957 | 0.250 |
Why?
|
| Cardiomegaly | 3 | 2015 | 593 | 0.250 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 5496 | 0.240 |
Why?
|
| Inflammation | 8 | 2024 | 10756 | 0.240 |
Why?
|
| Membrane Proteins | 5 | 2016 | 7850 | 0.240 |
Why?
|
| Carrier Proteins | 8 | 2021 | 4938 | 0.240 |
Why?
|
| Cell Communication | 2 | 2012 | 1653 | 0.240 |
Why?
|
| Hunger | 1 | 2006 | 206 | 0.230 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3047 | 0.230 |
Why?
|
| Aminopeptidases | 1 | 2004 | 95 | 0.220 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2018 | 52 | 0.220 |
Why?
|
| Protein Kinases | 3 | 2006 | 1612 | 0.220 |
Why?
|
| Islets of Langerhans | 6 | 2019 | 1345 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2016 | 8158 | 0.220 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 141 | 0.210 |
Why?
|
| Female | 75 | 2024 | 391270 | 0.210 |
Why?
|
| Stereoisomerism | 2 | 2021 | 617 | 0.210 |
Why?
|
| Feeding Behavior | 2 | 2006 | 3185 | 0.210 |
Why?
|
| Phosphoproteins | 10 | 2008 | 2440 | 0.210 |
Why?
|
| Esterification | 1 | 2022 | 39 | 0.210 |
Why?
|
| Insulin Antagonists | 1 | 2002 | 17 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2014 | 444 | 0.200 |
Why?
|
| Rats, Inbred Strains | 12 | 1991 | 2094 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2007 | 608 | 0.200 |
Why?
|
| src Homology Domains | 2 | 2000 | 361 | 0.200 |
Why?
|
| Glucagon | 4 | 2019 | 532 | 0.200 |
Why?
|
| Diglycerides | 1 | 2022 | 176 | 0.200 |
Why?
|
| Chromans | 1 | 2002 | 117 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 5785 | 0.190 |
Why?
|
| Molecular Structure | 3 | 2021 | 1895 | 0.190 |
Why?
|
| Organ Specificity | 11 | 2013 | 1955 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2014 | 2262 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases | 4 | 2010 | 203 | 0.190 |
Why?
|
| Potassium Channels | 2 | 2002 | 534 | 0.190 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.190 |
Why?
|
| Physical Conditioning, Animal | 3 | 2018 | 366 | 0.180 |
Why?
|
| Ion Channels | 4 | 2011 | 1043 | 0.180 |
Why?
|
| Molecular Sequence Data | 15 | 2016 | 17624 | 0.180 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 263 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2005 | 330 | 0.180 |
Why?
|
| Tyrosine | 8 | 2005 | 1438 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 368 | 0.180 |
Why?
|
| Coculture Techniques | 2 | 2016 | 1342 | 0.170 |
Why?
|
| Adenoviridae | 7 | 2005 | 1084 | 0.170 |
Why?
|
| Metabolome | 2 | 2021 | 982 | 0.170 |
Why?
|
| Denervation | 1 | 2021 | 277 | 0.170 |
Why?
|
| Plant Proteins | 1 | 2002 | 370 | 0.170 |
Why?
|
| Kinetics | 12 | 2009 | 6377 | 0.170 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2013 | 296 | 0.170 |
Why?
|
| Oxygen | 4 | 2010 | 4193 | 0.170 |
Why?
|
| Joint Prosthesis | 2 | 2016 | 253 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2015 | 8525 | 0.170 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 244 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4407 | 0.160 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1365 | 0.160 |
Why?
|
| Protein Isoforms | 4 | 2012 | 1697 | 0.160 |
Why?
|
| Glucosamine | 1 | 1999 | 128 | 0.160 |
Why?
|
| HLA Antigens | 1 | 2004 | 1368 | 0.150 |
Why?
|
| Body Mass Index | 9 | 2021 | 12914 | 0.150 |
Why?
|
| Body Composition | 10 | 2017 | 2419 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2017 | 2873 | 0.150 |
Why?
|
| Integrases | 2 | 2013 | 516 | 0.150 |
Why?
|
| Palmitic Acids | 1 | 2017 | 52 | 0.150 |
Why?
|
| Adiposity | 4 | 2018 | 1858 | 0.150 |
Why?
|
| Feces | 1 | 2024 | 1455 | 0.150 |
Why?
|
| Acetyl-CoA Carboxylase | 4 | 2007 | 72 | 0.150 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6538 | 0.150 |
Why?
|
| Cell Membrane | 11 | 2016 | 3682 | 0.150 |
Why?
|
| Phlorhizin | 3 | 2017 | 37 | 0.140 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2414 | 0.140 |
Why?
|
| Myostatin | 1 | 2018 | 127 | 0.140 |
Why?
|
| Genes, Dominant | 3 | 2010 | 863 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4357 | 0.140 |
Why?
|
| Overweight | 1 | 2008 | 2421 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 154 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 1 | 2018 | 260 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 3 | 2015 | 51 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2001 | 393 | 0.140 |
Why?
|
| Proteins | 5 | 2002 | 6029 | 0.140 |
Why?
|
| Carboxylesterase | 1 | 2016 | 31 | 0.140 |
Why?
|
| Biological Transport, Active | 4 | 2000 | 327 | 0.140 |
Why?
|
| Methylglucosides | 4 | 1990 | 35 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2018 | 361 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2019 | 1456 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 4 | 2005 | 134 | 0.130 |
Why?
|
| Sulfonylurea Compounds | 2 | 1995 | 221 | 0.130 |
Why?
|
| Chromatography, Liquid | 2 | 2018 | 987 | 0.130 |
Why?
|
| Brain | 8 | 2016 | 26951 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 128 | 0.130 |
Why?
|
| Cytochalasin B | 6 | 2017 | 74 | 0.130 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 255 | 0.130 |
Why?
|
| Gliclazide | 1 | 1995 | 3 | 0.130 |
Why?
|
| Energy Intake | 5 | 2011 | 2129 | 0.130 |
Why?
|
| Hydrolases | 1 | 2016 | 146 | 0.130 |
Why?
|
| Hormones, Ectopic | 2 | 2005 | 37 | 0.120 |
Why?
|
| ras Proteins | 3 | 1999 | 1052 | 0.120 |
Why?
|
| Hyperinsulinism | 7 | 2008 | 402 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2022 | 1398 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2021 | 542 | 0.120 |
Why?
|
| Hypertension | 1 | 2015 | 8594 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 998 | 0.120 |
Why?
|
| Angiotensin II | 2 | 2015 | 849 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Thiazoles | 1 | 2002 | 1511 | 0.120 |
Why?
|
| Weight-Bearing | 1 | 2017 | 518 | 0.120 |
Why?
|
| Myocardial Contraction | 1 | 1999 | 1516 | 0.120 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2014 | 61 | 0.120 |
Why?
|
| Ornithine Decarboxylase | 1 | 2014 | 64 | 0.120 |
Why?
|
| Spermine | 1 | 2014 | 69 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 251 | 0.120 |
Why?
|
| Middle Aged | 31 | 2021 | 220352 | 0.120 |
Why?
|
| Base Sequence | 9 | 2008 | 12446 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 789 | 0.110 |
Why?
|
| Thyrotropin | 2 | 1988 | 832 | 0.110 |
Why?
|
| COS Cells | 4 | 2002 | 1129 | 0.110 |
Why?
|
| Immune System | 1 | 2019 | 798 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2018 | 4264 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2014 | 132 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2014 | 96 | 0.110 |
Why?
|
| Adult | 34 | 2021 | 219994 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2010 | 2668 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 410 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3517 | 0.110 |
Why?
|
| Immunoblotting | 8 | 2017 | 1649 | 0.110 |
Why?
|
| Liver Glycogen | 3 | 2005 | 35 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2021 | 829 | 0.110 |
Why?
|
| Reference Values | 8 | 2008 | 4925 | 0.110 |
Why?
|
| Acetyltransferases | 1 | 2014 | 231 | 0.110 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 213 | 0.100 |
Why?
|
| Naphthalimides | 1 | 2012 | 22 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3804 | 0.100 |
Why?
|
| 3-O-Methylglucose | 5 | 1998 | 37 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 2919 | 0.100 |
Why?
|
| Cell Size | 5 | 2017 | 624 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 704 | 0.100 |
Why?
|
| Agouti-Related Protein | 1 | 2012 | 93 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 366 | 0.100 |
Why?
|
| Cell Line | 10 | 2016 | 15620 | 0.100 |
Why?
|
| Niacinamide | 1 | 2014 | 414 | 0.100 |
Why?
|
| Myocardium | 4 | 2017 | 4700 | 0.100 |
Why?
|
| Antimetabolites | 1 | 2012 | 128 | 0.100 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2005 | 40 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 581 | 0.100 |
Why?
|
| Proteome | 1 | 2021 | 1855 | 0.100 |
Why?
|
| Hexokinase | 2 | 2005 | 125 | 0.100 |
Why?
|
| Rats, Zucker | 3 | 2000 | 132 | 0.100 |
Why?
|
| Obesity, Morbid | 2 | 2020 | 1287 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 11345 | 0.090 |
Why?
|
| Time Factors | 14 | 2021 | 40165 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10446 | 0.090 |
Why?
|
| Blood Proteins | 1 | 1996 | 1173 | 0.090 |
Why?
|
| Adrenergic Antagonists | 1 | 2011 | 26 | 0.090 |
Why?
|
| Crosses, Genetic | 4 | 2013 | 751 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2010 | 224 | 0.090 |
Why?
|
| Blotting, Northern | 5 | 2000 | 1543 | 0.090 |
Why?
|
| Vasodilation | 1 | 2015 | 962 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 669 | 0.090 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2003 | 43 | 0.090 |
Why?
|
| Glucose-6-Phosphate | 2 | 2005 | 29 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 587 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 2016 | 487 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2016 | 11481 | 0.090 |
Why?
|
| Exercise | 4 | 2006 | 5787 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 2825 | 0.090 |
Why?
|
| Hepatocytes | 4 | 2021 | 1229 | 0.090 |
Why?
|
| NAD | 1 | 2014 | 609 | 0.090 |
Why?
|
| Adiponectin | 3 | 2013 | 1115 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 80 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2009 | 4899 | 0.090 |
Why?
|
| DNA-Binding Proteins | 6 | 2008 | 9585 | 0.090 |
Why?
|
| Spleen | 1 | 2016 | 2298 | 0.080 |
Why?
|
| Microsomes | 4 | 1997 | 252 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1997 | 1728 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 1991 | 406 | 0.080 |
Why?
|
| Food | 3 | 1990 | 771 | 0.080 |
Why?
|
| Sympathetic Nervous System | 2 | 2003 | 520 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1753 | 0.080 |
Why?
|
| Amino Acid Sequence | 9 | 2016 | 13451 | 0.080 |
Why?
|
| Podocytes | 1 | 2013 | 402 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1617 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 932 | 0.080 |
Why?
|
| Genetic Vectors | 3 | 2001 | 3380 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 174 | 0.080 |
Why?
|
| Cromolyn Sodium | 1 | 2009 | 77 | 0.080 |
Why?
|
| Streptozocin | 3 | 1997 | 194 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 491 | 0.080 |
Why?
|
| Heterozygote | 1 | 2016 | 2798 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2012 | 554 | 0.080 |
Why?
|
| Symporters | 2 | 2003 | 361 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2012 | 943 | 0.080 |
Why?
|
| Enzyme Inhibitors | 6 | 2011 | 3726 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3392 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 1526 | 0.080 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1987 | 100 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 1993 | 892 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2006 | 959 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1430 | 0.070 |
Why?
|
| Methylglycosides | 1 | 1987 | 10 | 0.070 |
Why?
|
| Estrogens | 1 | 2014 | 1520 | 0.070 |
Why?
|
| Receptors, Leptin | 2 | 2011 | 350 | 0.070 |
Why?
|
| Resistin | 2 | 2005 | 172 | 0.070 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 1999 | 86 | 0.070 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 532 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 2008 | 107 | 0.070 |
Why?
|
| Aorta | 1 | 2015 | 2039 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Ketone Bodies | 1 | 2007 | 76 | 0.070 |
Why?
|
| DNA | 5 | 1997 | 7233 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2013 | 3735 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 320 | 0.070 |
Why?
|
| Genotype | 3 | 2017 | 12960 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2012 | 858 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2006 | 85 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2006 | 114 | 0.070 |
Why?
|
| Transfection | 7 | 2007 | 5781 | 0.070 |
Why?
|
| Cathepsins | 1 | 2007 | 242 | 0.070 |
Why?
|
| Intestine, Small | 1 | 1992 | 1207 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2006 | 2058 | 0.070 |
Why?
|
| Acute-Phase Proteins | 1 | 2007 | 250 | 0.070 |
Why?
|
| Glycogen Phosphorylase | 1 | 2005 | 15 | 0.070 |
Why?
|
| Cytokines | 6 | 2012 | 7343 | 0.070 |
Why?
|
| Gluconeogenesis | 1 | 2007 | 185 | 0.070 |
Why?
|
| Hypertrophy | 2 | 2018 | 555 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 412 | 0.060 |
Why?
|
| Phosphotyrosine | 2 | 2004 | 456 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 1744 | 0.060 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2002 | 40 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1987 | 356 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2012 | 1617 | 0.060 |
Why?
|
| Apyrase | 1 | 2008 | 373 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1385 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2008 | 7593 | 0.060 |
Why?
|
| DNA Primers | 5 | 2004 | 2819 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2013 | 1802 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 727 | 0.060 |
Why?
|
| Glycerol | 2 | 2007 | 276 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 221 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2002 | 1652 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2001 | 839 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2012 | 1974 | 0.060 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 316 | 0.060 |
Why?
|
| Phosphotransferases | 2 | 2004 | 303 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3800 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 548 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2008 | 926 | 0.060 |
Why?
|
| Receptors, Melanocortin | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cystinyl Aminopeptidase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Fishes | 1 | 1987 | 601 | 0.060 |
Why?
|
| Fructose | 2 | 2017 | 287 | 0.060 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2007 | 261 | 0.060 |
Why?
|
| R-SNARE Proteins | 1 | 2004 | 75 | 0.060 |
Why?
|
| Mitochondria | 3 | 2018 | 3600 | 0.060 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 384 | 0.060 |
Why?
|
| Lipoproteins, VLDL | 1 | 2004 | 201 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2004 | 202 | 0.060 |
Why?
|
| Cell Fractionation | 2 | 1996 | 251 | 0.060 |
Why?
|
| Nurses | 1 | 2013 | 2467 | 0.050 |
Why?
|
| Cytosol | 2 | 1997 | 887 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 814 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 113 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 2 | 2004 | 333 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2001 | 478 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 719 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 271 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 412 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2004 | 2860 | 0.050 |
Why?
|
| Lactic Acid | 3 | 2007 | 1134 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 1988 | 665 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2013 | 18137 | 0.050 |
Why?
|
| Actins | 5 | 1998 | 2049 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 1132 | 0.050 |
Why?
|
| Cell Division | 4 | 2001 | 4463 | 0.050 |
Why?
|
| Carbon | 1 | 2006 | 669 | 0.050 |
Why?
|
| Feedback | 1 | 2006 | 791 | 0.050 |
Why?
|
| Phentolamine | 1 | 2002 | 102 | 0.050 |
Why?
|
| Lactates | 2 | 2001 | 404 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2005 | 1406 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.050 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 866 | 0.050 |
Why?
|
| Mast Cells | 1 | 2009 | 1390 | 0.050 |
Why?
|
| Androstadienes | 2 | 2001 | 348 | 0.050 |
Why?
|
| Hyperplasia | 2 | 2017 | 1155 | 0.050 |
Why?
|
| Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 20080 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 68 | 0.050 |
Why?
|
| Aurothioglucose | 2 | 2002 | 11 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10181 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2002 | 394 | 0.050 |
Why?
|
| DNA Replication | 2 | 1999 | 1412 | 0.050 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1999 | 350 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2002 | 100 | 0.050 |
Why?
|
| Aged | 15 | 2019 | 169152 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2012 | 25942 | 0.050 |
Why?
|
| Protein Transport | 3 | 2016 | 1964 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 125 | 0.050 |
Why?
|
| Hep G2 Cells | 2 | 2013 | 389 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3505 | 0.050 |
Why?
|
| Genistein | 1 | 2001 | 86 | 0.050 |
Why?
|
| Arthroplasty, Replacement | 1 | 2004 | 310 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1988 | 9185 | 0.040 |
Why?
|
| Portal Vein | 1 | 2003 | 429 | 0.040 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2004 | 377 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 345 | 0.040 |
Why?
|
| Cricetinae | 4 | 2011 | 2427 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2000 | 225 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2004 | 435 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 483 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2004 | 877 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2013 | 41335 | 0.040 |
Why?
|
| Physical Exertion | 2 | 1993 | 662 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 1959 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3775 | 0.040 |
Why?
|
| Health Status | 1 | 2013 | 4081 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1763 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2007 | 6551 | 0.040 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 575 | 0.040 |
Why?
|
| Vaginitis | 1 | 1999 | 48 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2002 | 706 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 1755 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 975 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5253 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 1999 | 44 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2003 | 965 | 0.040 |
Why?
|
| Doxycycline | 1 | 2001 | 341 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1999 | 122 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 818 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1998 | 14 | 0.040 |
Why?
|
| Thermosensing | 1 | 2018 | 55 | 0.040 |
Why?
|
| Homozygote | 1 | 2003 | 1788 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 389 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2013 | 5990 | 0.040 |
Why?
|
| Solid Phase Extraction | 1 | 2018 | 28 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2003 | 968 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2008 | 1242 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2000 | 294 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2004 | 943 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 665 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2004 | 1529 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 1843 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1998 | 169 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4000 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2008 | 380 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 12 | 0.040 |
Why?
|
| Adipocytes, Brown | 1 | 2018 | 149 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2002 | 1850 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1997 | 67 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2017 | 61 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 100 | 0.040 |
Why?
|
| Hip Dislocation | 1 | 2000 | 246 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 2000 | 1201 | 0.040 |
Why?
|
| Survivors | 4 | 2003 | 2375 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 57 | 0.040 |
Why?
|
| Quality of Life | 4 | 2003 | 13308 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2005 | 1204 | 0.030 |
Why?
|
| Indinavir | 1 | 2016 | 73 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2016 | 1693 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 1928 | 0.030 |
Why?
|
| Aging | 5 | 2003 | 8651 | 0.030 |
Why?
|
| Life Style | 2 | 2007 | 3896 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 10827 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2021 | 638 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 161 | 0.030 |
Why?
|
| Tritium | 1 | 2017 | 707 | 0.030 |
Why?
|
| Hemostasis | 1 | 1999 | 468 | 0.030 |
Why?
|
| CHO Cells | 3 | 2011 | 1389 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 2234 | 0.030 |
Why?
|
| Methionine | 1 | 1999 | 569 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2018 | 6360 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2016 | 114 | 0.030 |
Why?
|
| Antibodies | 3 | 1995 | 2421 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 2895 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 877 | 0.030 |
Why?
|
| Organ Size | 2 | 1999 | 2254 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2017 | 169 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 316 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1999 | 911 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 1996 | 114 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2001 | 1553 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2016 | 1792 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1995 | 56 | 0.030 |
Why?
|
| Weight Loss | 2 | 2007 | 2686 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2018 | 388 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 1996 | 134 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1737 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 477 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2016 | 191 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 616 | 0.030 |
Why?
|
| Longevity | 1 | 2003 | 1050 | 0.030 |
Why?
|
| Phenotype | 4 | 2011 | 16546 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4541 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1484 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 241 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 2558 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 1186 | 0.030 |
Why?
|
| Lipase | 1 | 2017 | 324 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2802 | 0.030 |
Why?
|
| Epididymis | 2 | 1993 | 228 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 1995 | 262 | 0.030 |
Why?
|
| Integrins | 1 | 1999 | 839 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 418 | 0.030 |
Why?
|
| Ribosomes | 1 | 1998 | 501 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2016 | 243 | 0.030 |
Why?
|
| Mycobacterium | 1 | 2016 | 250 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8482 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5643 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 1998 | 670 | 0.030 |
Why?
|
| Food Deprivation | 1 | 1994 | 114 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 6131 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2016 | 4169 | 0.030 |
Why?
|
| Metformin | 1 | 2002 | 912 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 695 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1994 | 157 | 0.030 |
Why?
|
| Vagina | 1 | 1999 | 837 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
| Peptides | 4 | 1995 | 4354 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 586 | 0.030 |
Why?
|
| Pelvic Bones | 1 | 2016 | 270 | 0.030 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1996 | 314 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2016 | 313 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1995 | 313 | 0.030 |
Why?
|
| Physical Examination | 1 | 1999 | 1244 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 1994 | 144 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 286 | 0.030 |
Why?
|
| Epinephrine | 1 | 2016 | 791 | 0.030 |
Why?
|
| Genes | 3 | 1993 | 1845 | 0.030 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 394 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1992 | 107 | 0.030 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2013 | 67 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1999 | 1206 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 1835 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 1411 | 0.030 |
Why?
|
| Caloric Restriction | 2 | 2007 | 296 | 0.030 |
Why?
|
| Creatine Kinase | 2 | 2007 | 691 | 0.030 |
Why?
|
| Membranes | 1 | 1992 | 165 | 0.030 |
Why?
|
| Breast Neoplasms | 4 | 2003 | 21025 | 0.030 |
Why?
|
| Prediabetic State | 2 | 2013 | 550 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2012 | 28 | 0.030 |
Why?
|
| Menopause | 1 | 2000 | 1640 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1992 | 78 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2018 | 1513 | 0.020 |
Why?
|
| Infusions, Intraventricular | 1 | 2011 | 32 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 193 | 0.020 |
Why?
|
| Microtubules | 1 | 1998 | 1072 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 237 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2011 | 47 | 0.020 |
Why?
|
| Haplorhini | 1 | 1992 | 529 | 0.020 |
Why?
|
| Glucosephosphates | 1 | 1991 | 20 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1996 | 782 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 534 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1594 | 0.020 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 1370 | 0.020 |
Why?
|
| Rodentia | 1 | 1992 | 260 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 852 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 1999 | 1717 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 1296 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1994 | 640 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 1998 | 919 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1994 | 563 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 290 | 0.020 |
Why?
|
| Acromegaly | 1 | 1993 | 306 | 0.020 |
Why?
|
| Postmenopause | 1 | 1999 | 2509 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2001 | 120 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 1994 | 873 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1991 | 2471 | 0.020 |
Why?
|
| Rabbits | 2 | 1995 | 4773 | 0.020 |
Why?
|
| Pancreas | 2 | 2008 | 1677 | 0.020 |
Why?
|
| Hip Prosthesis | 1 | 2016 | 920 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 93 | 0.020 |
Why?
|
| Albuminuria | 1 | 2013 | 659 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2013 | 1167 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 1990 | 211 | 0.020 |
Why?
|
| Cell Separation | 1 | 1995 | 1720 | 0.020 |
Why?
|
| Duodenum | 1 | 1992 | 486 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1997 | 1927 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 551 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6898 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 1992 | 449 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4573 | 0.020 |
Why?
|
| Adolescent | 5 | 2009 | 87810 | 0.020 |
Why?
|
| Multigene Family | 1 | 1992 | 1077 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2004 | 3763 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 959 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 1933 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 963 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 791 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1988 | 139 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3707 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2105 | 0.020 |
Why?
|
| Ictaluridae | 1 | 1987 | 8 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15789 | 0.020 |
Why?
|
| Aspartic Acid | 2 | 2000 | 576 | 0.020 |
Why?
|
| Epithelium | 1 | 1992 | 1605 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1988 | 366 | 0.020 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1993 | 739 | 0.020 |
Why?
|
| Farnesyltranstransferase | 2 | 1999 | 71 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2007 | 68 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2008 | 14495 | 0.020 |
Why?
|
| Oocytes | 1 | 1992 | 1165 | 0.020 |
Why?
|
| Exons | 1 | 1993 | 2388 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 1996 | 2628 | 0.020 |
Why?
|
| Nucleotidases | 1 | 1987 | 29 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5125 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 858 | 0.020 |
Why?
|
| NADH Dehydrogenase | 1 | 1987 | 46 | 0.020 |
Why?
|
| Goats | 1 | 1987 | 167 | 0.020 |
Why?
|
| Knee Joint | 1 | 2016 | 1663 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1997 | 1977 | 0.020 |
Why?
|
| Heart | 2 | 1998 | 4393 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 130 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 1356 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 2209 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1189 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 39261 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 80372 | 0.020 |
Why?
|
| Lipocalins | 1 | 2007 | 161 | 0.020 |
Why?
|
| Horses | 1 | 1987 | 298 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2008 | 1993 | 0.020 |
Why?
|
| Phosphorus | 1 | 1987 | 333 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 988 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1634 | 0.020 |
Why?
|
| Models, Animal | 2 | 2004 | 2117 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 1988 | 235 | 0.020 |
Why?
|
| Motor Activity | 2 | 2007 | 2687 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2005 | 3442 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 1987 | 161 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2209 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2629 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 1118 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2005 | 15697 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 1987 | 276 | 0.020 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2005 | 12 | 0.020 |
Why?
|
| Fibroblasts | 3 | 2005 | 4090 | 0.020 |
Why?
|
| Germany | 1 | 2007 | 873 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2013 | 1057 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1994 | 1274 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1705 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 237 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 1992 | 1399 | 0.010 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2005 | 85 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 606 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 9335 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 503 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2008 | 1085 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2004 | 163 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2005 | 195 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2004 | 264 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1347 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2005 | 281 | 0.010 |
Why?
|
| Fibronectins | 1 | 2007 | 722 | 0.010 |
Why?
|
| Mutation | 2 | 2005 | 29932 | 0.010 |
Why?
|
| Placenta | 1 | 1992 | 1702 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 6068 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 697 | 0.010 |
Why?
|
| Pregnancy | 3 | 2008 | 29749 | 0.010 |
Why?
|
| Body Constitution | 1 | 2003 | 273 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1996 | 0.010 |
Why?
|
| Osteolysis | 1 | 2004 | 274 | 0.010 |
Why?
|
| Lactation | 1 | 2004 | 397 | 0.010 |
Why?
|
| Sirolimus | 2 | 2000 | 1547 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2001 | 231 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2007 | 1326 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2001 | 185 | 0.010 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 10 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2803 | 0.010 |
Why?
|
| Diaphragm | 1 | 2003 | 351 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2488 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 2418 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 299 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11071 | 0.010 |
Why?
|
| Risk Factors | 3 | 2013 | 74359 | 0.010 |
Why?
|
| Amino Acids | 1 | 2007 | 1714 | 0.010 |
Why?
|
| Sex Counseling | 1 | 2000 | 17 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1990 | 2415 | 0.010 |
Why?
|
| Temperature | 1 | 1987 | 2221 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2005 | 656 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1988 | 1266 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2001 | 825 | 0.010 |
Why?
|
| Sexual Behavior | 2 | 2003 | 2086 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1064 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2003 | 403 | 0.010 |
Why?
|
| Amenorrhea | 1 | 2003 | 480 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1988 | 1607 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 2001 | 217 | 0.010 |
Why?
|
| Sex Factors | 1 | 1993 | 10547 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12159 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 474 | 0.010 |
Why?
|
| Length of Stay | 2 | 2005 | 6479 | 0.010 |
Why?
|
| Demography | 2 | 1996 | 1650 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2001 | 449 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 2000 | 195 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2000 | 190 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 1115 | 0.010 |
Why?
|
| Reproduction | 1 | 2003 | 646 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 1894 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1999 | 119 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 1999 | 86 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 542 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1999 | 186 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10551 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 1999 | 298 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 221 | 0.010 |
Why?
|
| Ouabain | 1 | 1998 | 247 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1407 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1992 | 2421 | 0.010 |
Why?
|
| Calmodulin | 1 | 1998 | 217 | 0.010 |
Why?
|
| Mammals | 1 | 2003 | 1131 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 835 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7408 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 2135 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2000 | 261 | 0.010 |
Why?
|
| Research Design | 1 | 2013 | 6180 | 0.010 |
Why?
|
| Alcoholism | 1 | 1988 | 1961 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3215 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 775 | 0.010 |
Why?
|
| Vaginal Smears | 1 | 1999 | 495 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 2000 | 4291 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 934 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 1999 | 535 | 0.010 |
Why?
|
| Transferases | 1 | 1996 | 72 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 675 | 0.010 |
Why?
|
| Hexoses | 1 | 1995 | 29 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 6048 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 2846 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15687 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1995 | 51 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 1995 | 62 | 0.010 |
Why?
|
| Chromones | 1 | 1996 | 149 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6465 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3465 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2879 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22053 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 3839 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2003 | 3529 | 0.010 |
Why?
|
| Flavonoids | 1 | 1998 | 445 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2013 | 54303 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 1991 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 16939 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1999 | 792 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 2502 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1995 | 213 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2057 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2000 | 868 | 0.010 |
Why?
|
| Atrophy | 1 | 1999 | 1627 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2005 | 58995 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 3301 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2753 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2008 | 65017 | 0.010 |
Why?
|
| Glyburide | 1 | 1994 | 114 | 0.010 |
Why?
|
| Calcium | 2 | 1998 | 5725 | 0.010 |
Why?
|
| Somatomedins | 1 | 1993 | 178 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1602 | 0.010 |
Why?
|
| Morpholines | 1 | 1996 | 583 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 3663 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2001 | 1380 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 660 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1992 | 422 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1992 | 132 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1993 | 548 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9287 | 0.010 |
Why?
|
| Pancreas Transplantation | 1 | 1993 | 196 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 2696 | 0.010 |
Why?
|
| Immune Sera | 1 | 1992 | 613 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3604 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 2347 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1994 | 1121 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1991 | 112 | 0.010 |
Why?
|
| Biopsy | 2 | 1993 | 6771 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1990 | 71 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2907 | 0.010 |
Why?
|
| Smoking | 1 | 1988 | 9073 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 2566 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 1990 | 190 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 2315 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 6216 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1992 | 2186 | 0.010 |
Why?
|
| Potassium | 1 | 1994 | 1313 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1990 | 557 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 4466 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 6965 | 0.010 |
Why?
|
| Hippocampus | 1 | 2002 | 3738 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 2001 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 865 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1992 | 788 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9411 | 0.000 |
Why?
|
| Renin-Angiotensin System | 1 | 1992 | 738 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3446 | 0.000 |
Why?
|
| Risk | 1 | 1999 | 9631 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15757 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3280 | 0.000 |
Why?
|
| HIV Infections | 1 | 1992 | 17165 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1994 | 2007 | 0.000 |
Why?
|
| Social Support | 1 | 1996 | 2145 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17790 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1993 | 4035 | 0.000 |
Why?
|
| Affect | 1 | 1992 | 1480 | 0.000 |
Why?
|
| Mass Screening | 1 | 2000 | 5423 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 14660 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 2197 | 0.000 |
Why?
|
| Neuroblastoma | 1 | 1992 | 1252 | 0.000 |
Why?
|
| United States | 1 | 2012 | 72461 | 0.000 |
Why?
|
| RNA | 1 | 1993 | 2722 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1992 | 2417 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 3448 | 0.000 |
Why?
|
| Psychometrics | 1 | 1992 | 3051 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 58741 | 0.000 |
Why?
|
| Child | 1 | 2009 | 79806 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36290 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1993 | 4215 | 0.000 |
Why?
|
| Glioma | 1 | 1992 | 3420 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6315 | 0.000 |
Why?
|